These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Conversion of beta-human atrial natriuretic polypeptide into alpha-human atrial natriuretic polypeptide in human plasma in vitro. Itoh H; Nakao K; Shiono S; Mukoyama M; Morii N; Sugawara A; Yamada T; Saito Y; Arai H; Kambayashi Y Biochem Biophys Res Commun; 1987 Mar; 143(2):560-9. PubMed ID: 2952117 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. Sugawara A; Nakao K; Morii N; Yamada T; Itoh H; Shiono S; Saito Y; Mukoyama M; Arai H; Nishimura K J Clin Invest; 1988 Jun; 81(6):1962-70. PubMed ID: 2968368 [TBL] [Abstract][Full Text] [Related]
4. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension]. Mori K Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713 [TBL] [Abstract][Full Text] [Related]
5. The effects of intravenous injection of alpha-human atrial natriuretic polypeptide on blood pressure, renal hemodynamics and urinary kinin excretion in anesthetized rabbits. Nushiro N; Abe K; Seino M; Omata K; Yoshinaga K Tohoku J Exp Med; 1987 Feb; 151(2):221-31. PubMed ID: 2953089 [TBL] [Abstract][Full Text] [Related]
6. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757 [TBL] [Abstract][Full Text] [Related]
7. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient]. Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999 [TBL] [Abstract][Full Text] [Related]
8. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension]. Mori K; Shigetomi S; Kohno H; Tosaki H; Kato K; Tanaka K; Haga H; Kin S; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):83-93. PubMed ID: 2158911 [TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of alpha-human natriuretic peptide produces a prolonged diuresis in healthy man. Shionoiri H; Kaneko Y Life Sci; 1986 Mar; 38(9):773-8. PubMed ID: 2936943 [TBL] [Abstract][Full Text] [Related]
10. Plasma arginine-vasopressin levels during infusion of synthetic atrial natriuretic peptide on different sodium intakes in man. Gnädinger MP; Weidmann P; Rascher W; Lang RE; Hellmüller B; Uehlinger DE J Hypertens; 1986 Oct; 4(5):623-9. PubMed ID: 2947950 [TBL] [Abstract][Full Text] [Related]
11. Effect of intracerebroventricular atrial natriuretic polypeptide on blood pressure and urine production in rats. Shimizu T; Katsuura G; Nakamura M; Nakao K; Morii N; Itoh Y; Shiono S; Imura H Life Sci; 1986 Oct; 39(14):1263-70. PubMed ID: 2945065 [TBL] [Abstract][Full Text] [Related]
12. Effects of alpha-human natriuretic peptide on renal hemodynamics and diuresis in dogs and perfused rat kidneys. Watanabe I; Goto F Jpn Circ J; 1994 Feb; 58(2):136-42. PubMed ID: 8196155 [TBL] [Abstract][Full Text] [Related]
13. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis. Waldhäusl W; Vierhapper H; Nowotny P J Clin Endocrinol Metab; 1986 May; 62(5):956-9. PubMed ID: 2937802 [TBL] [Abstract][Full Text] [Related]
14. The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man; effects of indomethacin. Miyamori I; Ikeda M; Matsubara T; Okamoto S; Koshida H; Yasuhara S; Morise T; Takeda R Br J Clin Pharmacol; 1987 Apr; 23(4):425-31. PubMed ID: 2953384 [TBL] [Abstract][Full Text] [Related]
15. Effects of synthetic human atrial natriuretic peptide (hANP) in conscious dogs. Johannessen AC; Schütten HJ; Torp-Pedersen C; Warberg J; Bie P Acta Physiol Scand; 1986 Aug; 127(4):449-54. PubMed ID: 2944353 [TBL] [Abstract][Full Text] [Related]
16. An oxidized analog of alpha-human atrial natriuretic polypeptide is a selective agonist for the atrial-natriuretic-polypeptide clearance receptor which lacks a guanylate cyclase. Koyama S; Terai T; Inoue T; Inomata K; Tamura K; Kobayashi Y; Kyogoku Y; Kobayashi M Eur J Biochem; 1992 Feb; 203(3):425-32. PubMed ID: 1346519 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome. Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385 [TBL] [Abstract][Full Text] [Related]
18. Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers. Delabays A; Porchet M; Waeber B; Nussberger J; Brunner HR J Cardiovasc Pharmacol; 1989 Jan; 13(1):173-6. PubMed ID: 2468931 [TBL] [Abstract][Full Text] [Related]
19. Permissive action of glucocorticoid substitution therapy on the effects of atrial natriuretic peptide (hANP) in patients with adrenocortical insufficiency. Damjancic P; Vierhapper H Exp Clin Endocrinol; 1990 Aug; 95(3):315-21. PubMed ID: 2174002 [TBL] [Abstract][Full Text] [Related]
20. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Igaki T; Itoh H; Suga SI; Hama N; Ogawa Y; Komatsu Y; Yamashita J; Doi K; Chun TH; Nakao K Hypertens Res; 1998 Mar; 21(1):7-13. PubMed ID: 9582102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]